关注
Yang Zhao
Yang Zhao
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
SC Wei, JH Levine, AP Cogdill, Y Zhao, NAAS Anang, MC Andrews, ...
Cell 170 (6), 1120-1133. e17, 2017
12042017
The chromatin accessibility landscape of primary human cancers
MR Corces, JM Granja, S Shams, BH Louie, JA Seoane, W Zhou, ...
Science 362 (6413), eaav1898, 2018
10142018
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
S Vijayaraghavan, C Karakas, I Doostan, X Chen, T Bui, M Yi, ...
Nature communications 8 (1), 15916, 2017
2722017
A genetic mouse model recapitulates immune checkpoint inhibitor–associated myocarditis and supports a mechanism-based therapeutic intervention
SC Wei, WC Meijers, ML Axelrod, NAAS Anang, EM Screever, ...
Cancer discovery 11 (3), 614-625, 2021
1892021
Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer
M Capello, LE Bantis, G Scelo, Y Zhao, P Li, DS Dhillon, NJ Patel, ...
JNCI: Journal of the National Cancer Institute 109 (4), djw266, 2017
1432017
Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple-negative breast cancer
JPW Carey, C Karakas, T Bui, X Chen, S Vijayaraghavan, Y Zhao, J Wang, ...
Cancer research 78 (3), 742-757, 2018
1202018
Diacetylspermine is a novel prediagnostic serum biomarker for non–small-cell lung cancer and has additive performance with pro-surfactant protein B
WR Wikoff, S Hanash, B DeFelice, S Miyamoto, M Barnett, Y Zhao, ...
Journal of clinical oncology 33 (33), 3880-3886, 2015
1122015
Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models
L Han, Q Zhang, M Dail, C Shi, A Cavazos, VR Ruvolo, Y Zhao, E Kim, ...
Haematologica 105 (3), 697, 2020
1002020
Negative co-stimulation constrains T cell differentiation by imposing boundaries on possible cell states
SC Wei, R Sharma, NAAS Anang, JH Levine, Y Zhao, JJ Mancuso, ...
Immunity 50 (4), 1084-1098. e10, 2019
932019
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun
X Xie, TS Kaoud, R Edupuganti, T Zhang, T Kogawa, Y Zhao, ...
Oncogene 36 (18), 2599-2608, 2017
902017
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders
CE Ang, Q Ma, OL Wapinski, SH Fan, RA Flynn, QY Lee, B Coe, ...
Elife 8, e41770, 2019
732019
Oral MEK 1/2 inhibitor trametinib in combination with AKT inhibitor GSK2141795 in patients with acute myeloid leukemia with RAS mutations: a phase II study
BK Ragon, O Odenike, MR Baer, W Stock, G Borthakur, K Patel, L Han, ...
Clinical Lymphoma Myeloma and Leukemia 19 (7), 431-440. e13, 2019
652019
Structural modularity of the XIST ribonucleoprotein complex
Z Lu, JK Guo, Y Wei, DR Dou, B Zarnegar, Q Ma, R Li, Y Zhao, F Liu, ...
Nature Communications 11 (1), 6163, 2020
632020
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy
YA Lyons, S Pradeep, SY Wu, M Haemmerle, JM Hansen, MJ Wagner, ...
Oncotarget 8 (57), 96496, 2017
632017
Elevation of TP53 autoantibody before CA125 in preclinical invasive epithelial ovarian cancer
WL Yang, A Gentry-Maharaj, A Simmons, A Ryan, EO Fourkala, Z Lu, ...
Clinical Cancer Research 23 (19), 5912-5922, 2017
602017
An Unexpected FeCl3-Catalyzed Cascade Reaction of Indoles and o-Hydroxychalcones for the Assembly of Chromane-Bridged Polycyclic Indoles
W Wang, X Bai, S Jin, J Guo, Y Zhao, H Miao, Y Zhu, Q Wang, Z Bu
Organic letters 20 (12), 3451-3454, 2018
542018
Defining survivorship trajectories across patients with solid tumors: an evidence-based approach
RL Dood, Y Zhao, SD Armbruster, RL Coleman, S Tworoger, AK Sood, ...
JAMA oncology 4 (11), 1519-1526, 2018
532018
Phosphine-catalyzed Friedel–Crafts reaction of naphthols with para-quinone methides: expedient access to triarylmethanes
T Zhou, S Li, B Huang, C Li, Y Zhao, J Chen, A Chen, Y Xiao, L Liu, ...
Organic & Biomolecular Chemistry 15 (23), 4941-4945, 2017
532017
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell …
Q Zhang, C Shi, L Han, N Jain, KG Roberts, H Ma, T Cai, A Cavazos, ...
Oncotarget 9 (8), 8027, 2018
522018
Xist ribonucleoproteins promote female sex-biased autoimmunity
DR Dou, Y Zhao, JA Belk, Y Zhao, KM Casey, DC Chen, R Li, B Yu, ...
Cell 187 (3), 733-749. e16, 2024
512024
系统目前无法执行此操作,请稍后再试。
文章 1–20